Halozyme Reports Second Quarter 2018 Results

Go back to Halozyme Reports Second Quarter 2018 Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 110.52 +0.84 (0.77%)
Previous Close $109.68    52 Week High $18.39 
Open $109.72    52 Week Low $6.96 
Day High $111.80    P/E N/A 
Day Low $109.38    EPS $-0.58 
Volume 2,889,546